Doctor Sayaka Funabashi
Kyorin University, Mitaka (Japan)
The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia
Event: ESC Congress 2022
Topic: Lipids
Session: Optimal risk factor therapy in high risk patients
Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease
Event: ESC Congress 2021 - The Digital Experience
Topic: Pathophysiology
Session: Risk Factors and Prevention ePosters
Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l
Event: ESC Congress 2020
Topic: Lipids
Session: Risk Factors and Prevention ePosters
Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Peripheral Vascular and Cerebrovascular Disease ePosters
Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria
Event: ESC Congress 2019
Topic: Clinical
Session: Comorbidities and prognosis in peripheral artery disease
Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure
Event: ESC Congress 2018
Topic: Biomarkers
Session: Best Posters in acute heart failure
ESC 365 is supported by
